155 related articles for article (PubMed ID: 26376154)
1. Dactinomycin in NPM1-Mutated Acute Myeloid Leukemia.
Falini B; Brunetti L; Martelli MP
N Engl J Med; 2015 Sep; 373(12):1180-2. PubMed ID: 26376154
[No Abstract] [Full Text] [Related]
2. Dactinomycin in acute myeloid leukemia with NPM1 mutations.
Beziat G; Tavitian S; Bertoli S; Huguet F; Largeaud L; Luquet I; Vergez F; Rieu JB; Bories P; Delabesse E; Récher C
Eur J Haematol; 2020 Sep; 105(3):302-307. PubMed ID: 32452083
[TBL] [Abstract][Full Text] [Related]
3. Dactinomycin induces complete remission associated with nucleolar stress response in relapsed/refractory NPM1-mutated AML.
Gionfriddo I; Brunetti L; Mezzasoma F; Milano F; Cardinali V; Ranieri R; Venanzi A; Pierangeli S; Vetro C; Spinozzi G; Dorillo E; Wu HC; Berthier C; Ciurnelli R; Griffin MJ; Jennings CE; Tiacci E; Sportoletti P; Falzetti F; de Thé H; Veal GJ; Martelli MP; Falini B
Leukemia; 2021 Sep; 35(9):2552-2562. PubMed ID: 33654209
[TBL] [Abstract][Full Text] [Related]
4. Acute myeloid leukemia with mutated NPM1 demonstrating multilineage dysplasia and marked thrombocytosis.
Chen Y; Pourabdollah M; Chang H
Br J Haematol; 2017 Aug; 178(3):350. PubMed ID: 28677819
[No Abstract] [Full Text] [Related]
5. Monitoring of minimal residual disease in NPM1-mutated acute myeloid leukemia: a study from the German-Austrian acute myeloid leukemia study group.
Krönke J; Schlenk RF; Jensen KO; Tschürtz F; Corbacioglu A; Gaidzik VI; Paschka P; Onken S; Eiwen K; Habdank M; Späth D; Lübbert M; Wattad M; Kindler T; Salih HR; Held G; Nachbaur D; von Lilienfeld-Toal M; Germing U; Haase D; Mergenthaler HG; Krauter J; Ganser A; Göhring G; Schlegelberger B; Döhner H; Döhner K
J Clin Oncol; 2011 Jul; 29(19):2709-16. PubMed ID: 21555683
[TBL] [Abstract][Full Text] [Related]
6. Acute myeloid leukaemia with mutated NPM1 presenting with extensive bone marrow necrosis and Charcot-Leyden crystals.
Taylor G; Ivey A; Milner B; Grimwade D; Culligan D
Int J Hematol; 2013 Sep; 98(3):267-8. PubMed ID: 23884732
[TBL] [Abstract][Full Text] [Related]
7. Acute myeloid leukemia with mutated nucleophosmin (NPM1): any hope for a targeted therapy?
Falini B; Gionfriddo I; Cecchetti F; Ballanti S; Pettirossi V; Martelli MP
Blood Rev; 2011 Nov; 25(6):247-54. PubMed ID: 21724308
[TBL] [Abstract][Full Text] [Related]
8. A one-mutation mathematical model can explain the age incidence of acute myeloid leukemia with mutated nucleophosmin (NPM1).
Liso A; Castiglione F; Cappuccio A; Stracci F; Schlenk RF; Amadori S; Thiede C; Schnittger S; Valk PJ; Döhner K; Martelli MF; Schaich M; Krauter J; Ganser A; Martelli MP; Bolli N; Löwenberg B; Haferlach T; Ehninger G; Mandelli F; Döhner H; Michor F; Falini B
Haematologica; 2008 Aug; 93(8):1219-26. PubMed ID: 18603563
[TBL] [Abstract][Full Text] [Related]
9. Multilineage dysplasia is associated with a poorer prognosis in patients with de novo acute myeloid leukemia with intermediate-risk cytogenetics and wild-type NPM1.
Rozman M; Navarro JT; Arenillas L; Aventín A; Giménez T; Alonso E; Perea G; Camós M; Navarrete M; Tuset E; Florensa L; Millá F; Nomdedéu J; de la Banda E; Díaz-Beyá M; Pratcorona M; Garrido A; Navarro B; Brunet S; Sierra J; Esteve J;
Ann Hematol; 2014 Oct; 93(10):1695-703. PubMed ID: 24824767
[TBL] [Abstract][Full Text] [Related]
10. Cytoplasmic expression of nucleophosmin accurately predicts mutation in the nucleophosmin gene in patients with acute myeloid leukemia and normal karyotype.
Luo J; Qi C; Xu W; Kamel-Reid S; Brandwein J; Chang H
Am J Clin Pathol; 2010 Jan; 133(1):34-40. PubMed ID: 20023256
[TBL] [Abstract][Full Text] [Related]
11. Acute myeloid leukemia with myelodysplasia-related changes are characterized by a specific molecular pattern with high frequency of ASXL1 mutations.
Devillier R; Gelsi-Boyer V; Brecqueville M; Carbuccia N; Murati A; Vey N; Birnbaum D; Mozziconacci MJ
Am J Hematol; 2012 Jul; 87(7):659-62. PubMed ID: 22535592
[TBL] [Abstract][Full Text] [Related]
12. [Neocarzinostatin. A new chemotherapeutic approach to acute leukemia (author's transl)].
Hiraki K; Kamimura O; Takahashi I; Nagao T; Kitajima K; Irino S
Nouv Rev Fr Hematol; 1973; 13(4):445-51. PubMed ID: 4271094
[No Abstract] [Full Text] [Related]
13. The cytological features of NPM1-mutated acute myeloid leukemia.
Bain BJ; Heller M; Toma S; Pavlů J
Am J Hematol; 2015 Jun; 90(6):560. PubMed ID: 25779376
[No Abstract] [Full Text] [Related]
14. Classification of CEBPA mutated acute myeloid leukemia by GATA2 mutations.
Marceau-Renaut A; Guihard S; Castaigne S; Dombret H; Preudhomme C; Cheok M
Am J Hematol; 2015 May; 90(5):E93-4. PubMed ID: 25611491
[No Abstract] [Full Text] [Related]
15. Long-term outcome of NPM1 mutated acute myeloid leukemia: A single-institution experience.
Sayar H; Bashardoust P; Cripe L; Chakraborty S; Bai S
Am J Hematol; 2017 Feb; 92(2):E17-E18. PubMed ID: 27813149
[No Abstract] [Full Text] [Related]
16. An unusual initial manifestation of acute leukemia.
Desai A; Desai A; Staszewski H; Cunha BA
Am J Med; 2012 Dec; 125(12):1173-4. PubMed ID: 23062401
[No Abstract] [Full Text] [Related]
17. Lack of noncanonical RAS mutations in cytogenetically normal acute myeloid leukemia.
Reuter CW; Krauter J; Onono FO; Bunke T; Damm F; Thol F; Wagner K; Göhring G; Schlegelberger B; Heuser M; Ganser A; Morgan MA
Ann Hematol; 2014 Jun; 93(6):977-82. PubMed ID: 24737308
[TBL] [Abstract][Full Text] [Related]
18. Rapid flow cytometric detection of aberrant cytoplasmic localization of nucleophosmin (NPMc) indicating mutant NPM1 gene in acute myeloid leukemia.
Oelschlaegel U; Koch S; Mohr B; Schaich M; Falini B; Ehninger G; Thiede C
Leukemia; 2010 Oct; 24(10):1813-6. PubMed ID: 20724983
[No Abstract] [Full Text] [Related]
19. Increase sensitivity to chemotherapeutical agents and cytoplasmatic interaction between NPM leukemic mutant and NF-kappaB in AML carrying NPM1 mutations.
Cilloni D; Messa F; Rosso V; Arruga F; Defilippi I; Carturan S; Catalano R; Pautasso M; Panuzzo C; Nicoli P; Messa E; Morotti A; Iacobucci I; Martinelli G; Bracco E; Saglio G
Leukemia; 2008 Jun; 22(6):1234-40. PubMed ID: 18401421
[TBL] [Abstract][Full Text] [Related]
20. Case 26-2021: A 49-Year-Old Man with Relapsed Acute Myeloid Leukemia.
Brunner AM; Newcomb RA; Chen YB; Crabbe AM
N Engl J Med; 2021 Aug; 385(9):834-843. PubMed ID: 34437787
[No Abstract] [Full Text] [Related]
[Next] [New Search]